Research Areas:

Nanotechnology-based biosensors for faster and more sensitive health diagnostics

Here, we focus on nano-biosensors tailored for specific conditions such as sepsis, cardiac disorders, cancers, and other infectious diseases. The aim is to develop portable and wearable platforms, including lateral flow assays (LFAs) and electrochemical sensors, that operate with minimal sample volume, provide rapid responses, and are compatible with smartphone- or handheld-based readouts for use in field and clinical settings.

Development of optically tunable nanomaterials for bioimaging applications

This area focuses on synthesizing and tuning optically active nanomaterials by controlling size, composition, doping, and surface chemistry to optimize fluorescence, stability, and biocompatibility. These nanomaterials will be functionalized with targeting ligands and evaluated for cellular, deep-tissue, and multimodal bioimaging, as well as toxicity and biodistribution assessments.

Antimicrobial nanomaterials for infection control and addressing drug resistance

In this research area, we design and optimize antimicrobial nanomaterials capable of killing or inhibiting multidrug-resistant pathogens and biofilms. Applications wiinclude coatings, disinfectants, and adjuncts to antibiotics, with systematic studies on mechanisms of action, efficacy, and cytotoxicity.

Nano formulated solutions for animal health

This project will develop Nano formulations for veterinary drugs, vaccines, and nutraceuticals to enhance stability, bioavailability, and controlled release. The overall goal is to improve therapeutic outcomes, reduce dosing frequency, and support animal health in both livestock and companion animals.

Poultry industry infection control using nanotechnology

The research focuses on nano-enabled strategies such as antimicrobial/anticoccidial drug delivery agents, nano-disinfectants, and nano-supplemented feed additives and toxin binders to control key infectious agents in poultry. These interventions will be evaluated under realistic farm conditions for efficacy, safety, impact on productivity, and residue levels in poultry products.

Targeted drug delivery using Nanotechnology

This area focuses on developing targeted drug delivery systems using nanotechnology to achieve site-specific delivery and controlled release of therapeutics. Nanocarriers such as polymeric nanoparticles, liposomes, and inorganic nanomaterials will be engineered and surface-functionalized with targeting ligands to enhance selective accumulation at diseased tissues. The aim is to enhance therapeutic efficacy while minimizing off-target effects and systemic toxicity, supported by in vitro and in vivo evaluations of release profiles and safety.